Stay updated on Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.0 to v3.5.2. No study record content or displayed trial information was added or removed.
    Difference
    0.1%
    Check dated 2026-04-21T01:09:25.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; removed Revision: v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-23T04:59:05.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the prior revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-08T23:52:20.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history.
    Difference
    0.1%
    Check dated 2026-02-15T12:30:59.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The study record history shows a new revision (v3.4.1) added and the previous revision (v3.4.0) removed.
    Difference
    0.1%
    Check dated 2026-02-08T04:57:00.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    UI updates include a glossary toggle, a color-coded legend for additions and deletions (green/red), and new revision notes (v3.4.0), with minor wording changes such as 'No FEAR Act Data'.
    Difference
    1%
    Check dated 2026-01-24T23:03:53.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.